Aclaris Therapeutics
PublicAclaris Therapeutics is now publicly traded
The data on this page reflects Aclaris Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Oct 6, 2015
Last Round
Private Placement
Nov 18, 2024
Est. Valuation at Exit
$295M
Total Funding Raised
$422.75M
Company Overview
Aclaris Therapeutics (NAS: ACRS) is a biopharmaceutical company focused on developing innovative drug candidates for immuno-inflammatory diseases while also providing laboratory services through its contract research segment.
Sector
Health Care
AI Layer
Non-AI
Keywords
Aclaris Therapeutics Comparables
Compare Aclaris Therapeutics with similar companies based on industry and business-model similarity.
No public comparables are available for Aclaris Therapeutics. Request access to learn about comparables coverage.
Request accessAclaris Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Nov 18, 2024 | ||||
| Follow-on Offering | Jun 9, 2021 | ||||
| Debt | Mar 31, 2020 | ||||
| Follow-on Offering | Nov 17, 2016 | ||||
| IPO | Oct 6, 2015 | ||||
Series B | Oct 2, 2014 |
Aclaris Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| RA Capital Management | Private Placement |
| Logos Capital | Private Placement |
| Forge Life Science Partners | Private Placement |
| Adage Capital Partners, L.P. | Private Placement |
| F-Prime Capital | Series B, Series A |
| William Blair & Company | IPO |
Aclaris Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access